๐Ÿงฌ Cancer Vaccines — Updated Overview (2025)

-

  By Dr. Sk Sabir Rahaman, MBBS, MD (Pharmacology), DFM(Family Medicine), FCFM, CCEBDM, CCLSD

๐Ÿ”น 1. Definition

Cancer vaccines are biological preparations that train the immune system to recognize and attack tumor cells.

They target:

  • Tumor-associated antigens (TAA): present in normal cells but overexpressed in cancers (e.g., AFP in hepatocellular carcinoma, HER2 in breast cancer).

  • Neoantigens: novel proteins created by tumor mutations, unique to cancer cells.

๐Ÿ‘‰ Aim: either prevent cancer (prophylactic vaccines) or treat established cancer (therapeutic vaccines).

๐Ÿ”น 2. Classification

A. Prophylactic (Preventive) Cancer Vaccines

  • Block infection with oncogenic viruses → prevent virus-driven cancers.

  • Examples:

    • HPV vaccines (Gardasil, Cervarix, Gardasil-9) → prevent cervical, vulvar, vaginal, anal, penile, and oropharyngeal cancers.

    • Hepatitis B vaccine → prevents chronic HBV infection, reducing hepatocellular carcinoma risk.

  • ✅ Clinically established, effective, and part of national immunization programs worldwide (including India with HPV rollout).

B. Therapeutic (Treatment) Cancer Vaccines

  • Activate cytotoxic CD8+ T cells and CD4+ helper T cells to kill tumor cells.

  • Examples:

    • Sipuleucel-T (Provenge): FDA-approved (2010) for metastatic prostate cancer.

    • Investigational: peptide vaccines (melanoma), dendritic cell vaccines (DCVax-L), mRNA vaccines (BioNTech/Moderna), personalized neoantigen vaccines.

  • ❗ Still experimental, often combined with checkpoint inhibitors (anti-PD-1, anti-CTLA-4).

๐Ÿ”น 3. Mechanism of Action

  1. Vaccine antigens (TAA/neoantigens) introduced.

  2. Captured by antigen-presenting cells (APCs) like dendritic cells.

  3. Presented via MHC I & II pathways.

  4. T-cell response:

    • CD8+ CTLs → direct tumor killing.

    • CD4+ T-helpers → sustain immune attack.

  5. Immune memory reduces recurrence.

  6. Adjuvants (e.g., GM-CSF, TLR agonists) boost response.

  7. Checkpoint inhibitors added to overcome tumor immune evasion.

๐Ÿ”น 4. Approaches to Cancer Vaccines

  • Whole tumor cell vaccines: killed or modified tumor cells.

  • Peptide/protein vaccines: e.g., gp100 in melanoma.

  • DNA/RNA vaccines: plasmids or mRNA encoding tumor antigens (BioNTech, Moderna).

  • Dendritic cell vaccines: patient’s DCs loaded with antigens (Sipuleucel-T, DCVax-L).

  • Neoantigen-based vaccines: fully personalized based on tumor sequencing.

  • Oncolytic virus-based vaccines: engineered viruses that infect and lyse tumor cells while expressing antigens.

๐Ÿ”น 5. Advantages

  • High specificity for tumor antigens.

  • Induce long-lasting immune memory.

  • Reduce recurrence risk.

  • Scope for precision oncology through personalization.

๐Ÿ”น 6. Limitations

  • Tumor immune evasion (↓ MHC, ↑ TGF-ฮฒ, IL-10).

  • Tumor heterogeneity → variable antigen expression.

  • Modest efficacy as monotherapy.

  • Costly and time-intensive personalization.

  • Less effective in immunosuppressed patients.

๐Ÿ”น 7. Current Status (2025)

Preventive Vaccines

  • HPV & HBV vaccines: established success.

  • EBV vaccines: in trials for lymphomas & nasopharyngeal carcinoma (not yet approved).

Therapeutic Vaccines

  • Sipuleucel-T → still the only FDA-approved therapeutic vaccine.

  • Neoantigen & mRNA vaccines → Phase II/III trials show encouraging results in melanoma, pancreatic cancer, renal cell carcinoma, and NSCLC.

  • Dendritic cell vaccines (DCVax-L): showing survival benefit in glioblastoma.

  • Combination with checkpoint inhibitors gives best outcomes.

๐Ÿ”น 8. International Perspective

  • Strong pipeline (2024–25): BioNTech, Moderna, GSK leading personalized vaccine trials.

  • Partnerships between pharma & academia are fast-tracking late-phase studies.

  • Early results: better tumor shrinkage and survival when vaccines are combined with immunotherapies.

  • Future trends:

    • Oncolytic viruses with tumor antigens.

    • Personalized mRNA vaccines adapted from COVID-19 platforms.

    • EBV-targeted vaccines for virus-driven cancers.

๐Ÿ”น 9. Indian Perspective

  • Preventive vaccines:

    • Cervavac (Serum Institute, 2022): low-cost quadrivalent HPV vaccine.

    • Govt. planning nationwide HPV rollout to reduce cervical cancer.

  • Manufacturing & Research:

    • Bharat Biotech (2025) set up advanced facilities for gene & cell therapy.

    • Indian pharma (Serum, Bharat, Zydus) investing in next-gen vaccine platforms.

  • Clinical trials:

    • Limited, but growing participation in global therapeutic vaccine research.

    • Primary focus: public health deployment of HPV vaccines.

๐Ÿ”น 10. Future Directions

  • Wider integration of personalized cancer vaccines into standard oncology care.

  • Combination regimens: vaccines + checkpoint inhibitors + chemotherapy.

  • Affordable platforms for global accessibility (key for India & LMICs).

  • Expansion of mRNA and viral vector platforms from infectious disease to cancer.

  • Possible approvals of EBV & neoantigen vaccines within the next decade.

๐ŸŒŸ Spotlight: Russia’s Enteromix mRNA Cancer Vaccine (2025)

At the 2025 St. Petersburg Economic Forum, Russia announced Enteromix, an mRNA cancer vaccine for colorectal cancer, reporting 100% efficacy in early trials (48 patients).

๐Ÿ”ฌ Key Highlights

  • Uses mRNA technology to encode patient-specific neoantigens.

  • Each dose is personalized using tumor genomic profiling.

  • Reported outcomes: all patients showed tumor shrinkage, no major side effects.

  • Govt. pledge: free access once approved.

⚠️ Caveats

  • Small sample size (48 patients).

  • No peer-reviewed publication yet.

  • Phase II/III validation needed across countries.

  • Logistical hurdles: genomic sequencing + rapid vaccine manufacturing.

๐ŸŒ Global & Indian Implications

  • If validated, could revolutionize cancer therapy → reduce dependence on chemotherapy/radiotherapy.

  • India, as a vaccine hub, could collaborate for affordable large-scale rollout.

  • Barriers: cost, infrastructure, regulatory approvals.

๐Ÿ‘‰ Bottom Line: Enteromix represents a bold step in personalized immuno-oncology. While promising, global validation and larger trials are essential before clinical adoption.

✅ Conclusion

  • Cancer vaccines are a fast-evolving frontier in oncology.

  • Preventive vaccines (HPV, HBV) → already saving lives worldwide.

  • Therapeutic vaccines (Sipuleucel-T, neoantigen/mRNA vaccines) → rapidly advancing but still under evaluation.

  • Enteromix (Russia, 2025) has generated excitement but requires careful global validation.

  • With the momentum of mRNA and personalized medicine, the next decade may witness cancer vaccines as mainstream therapy alongside immunotherapy and precision oncology.   


๐Ÿ“˜ Prepared by Dr. Sk Sabir Rahaman
๐Ÿ“ Specialist Family Physician | Consultant Pharmacologist | Lifestyle & Diabetes Expert

๐ŸŒ Visit My Website for Full Article & other Free PDFs and Resources

Comments

Post a Comment

Popular posts from this blog

๐Ÿฅ Insulin Storage: Myths vs. Facts Every Diabetic Should Know

-
By Dr. Sk Sabir Rahaman, MBBS , MD (Pharmacology), DFM(Family Medicine), FCFM, CCEBDM, CCLSD   For millions living with diabetes, insulin is more than a medication — it’s a lifeline . However, widespread misconceptions about insulin storage often lead to avoidable panic, especially during heatwaves, power outages, or while traveling . ๐Ÿšซ The Myth: "Insulin must always stay refrigerated" Many believe that insulin instantly loses effectiveness once it’s out of the fridge. This is not true — and can cause undue stress, particularly in hot climates like India or during journeys where refrigeration isn’t available. ✅ The Fact: Most insulin types tolerate room temperature According to World Health Organization (WHO) and insulin manufacturer guidelines : ๐Ÿ”น Opened insulin vials or pens can be safely kept at room temperature (15–25°C / 59–77°F) for up to 28 days. That means: You don’t need to return it to the fridge every time after injection. It's safe fo...
Read more

๐Ÿงด TREATMENT OF POISONING – A COMPREHENSIVE OVERVIEW

-
By Dr. Sk Sabir Rahaman, MBBS , MD (Pharmacology), DFM(Family Medicine), FCFM, CCEBDM, CCLSD   ๐Ÿงช Definition & Scope Toxicology : Branch of pharmacology dealing with harmful effects of chemicals on living organisms. Poisoning : Harmful effects caused by ingestion, inhalation, dermal exposure, or injection of toxic substances (drugs, pesticides, household chemicals, industrial agents, venoms). Medico-legal importance : All poisoning cases are medical emergencies. Must be reported to police/authorities (especially suicidal, homicidal, or accidental cases) under Indian law. ๐Ÿ›‘ General Principles of Management (ABCDE of Toxicological Emergencies) A – Airway Ensure patency (tongue fall, aspiration common in comatose patients). Place in left lateral position to reduce aspiration. Intubate with cuffed endotracheal tube if airway compromised. Regular suction of secretions. B – Breathing Monitor with pulse oximetry and ABG. Give humidified oxy...
Read more

๐ŸŒฟ Rational Use of Medicines (RUM): A Guide for Safer and Smarter Prescribing

-
By Dr. Sk Sabir Rahaman, MBBS , MD (Pharmacology), DFM(Family Medicine), FCFM, CCEBDM, CCLSD   ๐Ÿ“ Specialist Family Physician | Consultant Pharmacologist | Lifestyle & Diabetes Expert Medicines save lives, ease suffering, and improve health outcomes. But when they are used irrationally , they can cause more harm than good. The World Health Organization (WHO) emphasizes the importance of the Rational Use of Medicines (RUM) to ensure patient safety, treatment effectiveness, and cost efficiency. In this blog, we’ll explore what RUM means, why it matters, and how healthcare professionals can practice it effectively. ๐Ÿ“Œ What is Rational Use of Medicines? According to WHO: “Rational use of medicines requires that patients receive medications appropriate to their clinical needs, in doses that meet their individual requirements, for an adequate period of time, and at the lowest cost to them and their community.” In simple words: it’s about prescribing the right medicine, in t...
Read more